ZLAB Zai Lab Limited ADRs

Zai Lab Ltd is a biopharmaceutical company. The company is engaged in discovering or licensing, developing and commercializing proprietary therapeutics in the fields of oncology, autoimmune and infectious diseases. This is an ADR of a company that does not have its stock publicly traded anywhere else in the world.

$34.69  +0.14 (0.41%)
As of 06/30/2022 15:59:55 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  China
Country of incorporation:  Cayman Islands
IPO date:  09/20/2017
Outstanding shares:  97,908,743
Average volume:  805,502
Market cap:   $3,373,935,284
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BD9GVY0
Valuation   (See tab for details)
PE ratio:   -6.11
PB ratio:   2.53
PS ratio:   19.74
Return on equity:   -42.35%
Net income %:   -324.08%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy